Free Trial

Oncolytics Biotech (ONCY) Institutional Ownership

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)
Free ONCY Stock Alerts
$1.09
+0.01 (+0.93%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Oncolytics Biotech (NASDAQ:ONCY)

Current
Institutional Ownership
Percentage
6.82%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$501.89K
Number of
Institutional Sellers
(last 12 months)
0
Get ONCY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncolytics Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ONCY Institutional Buying and Selling by Quarter

Oncolytics Biotech Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/24/2024 International Assets Investment Management LLC269,699$364K0.0%+33.9%0.362%
1/12/2024 Advisor Resource Council100,000$135K0.0%N/A0.134%
1/11/2024 Ausdal Financial Partners Inc.30,000$40K0.0%+50.0%0.041%
11/8/2023 Ausdal Financial Partners Inc.20,000$44K0.0%N/A0.027%
10/13/2023Brave Asset Management Inc.25,000$55K0.0%+150.0%0.035%
10/10/2023 International Assets Investment Management LLC201,453$449K0.0%+3.3%0.278%
10/4/2023 International Assets Investment Management LLC201,453$449K0.0%+3.3%0.278%
8/23/2023Headinvest LLC11,534$30K0.0%N/A0.016%
8/2/2023Bank of Montreal Can32,380$85K0.0%N/A0.049%
7/24/2023Brave Asset Management Inc.10,000$26K0.0%N/A0.015%
7/20/2023 International Assets Investment Management LLC194,963$507K0.1%+3.4%0.297%
2/7/2023Lynwood Capital Management Inc.25,000$41K0.0%N/A0.041%
1/24/2023 International Assets Investment Management LLC169,111$609K0.1%-6.9%0.276%
1/20/2023Newman Dignan & Sheerar Inc.18,915$31K0.0%+46.5%0.031%
8/11/2022Toronto Dominion Bank35,362$34K0.0%N/A0.061%
7/27/2022 Advisor Resource Council100,000$101K0.0%N/A0.173%
2/14/2022Long Focus Capital Management LLC40,000$56K0.0%N/A0.073%
2/11/2022 Advisor Resource Council100,000$139K0.0%N/A0.182%
11/12/2021Renaissance Technologies LLC209,900$439K0.0%+812.6%0.382%
10/28/2021 International Assets Investment Management LLC170,576$357K0.1%+5.4%0.310%
10/7/2021Newman Dignan & Sheerar Inc.12,915$27K0.0%N/A0.023%
9/17/2021Virtu Financial LLC35,425$98K0.0%N/A0.064%
8/19/2021 Advisor Resource Council101,000$280K0.0%N/A0.184%
8/13/2021Renaissance Technologies LLC23,000$64K0.0%N/A0.042%
8/12/2021JPMorgan Chase & Co.150,673$919K0.0%+167.7%0.274%
8/12/2021Bank of Montreal Can16,460$46K0.0%+40.1%0.030%
7/31/2021Brave Asset Management Inc.20,000$55K0.0%+100.0%0.036%
5/21/2021Citadel Advisors LLC49,378$188K0.0%N/A0.093%
5/19/2021Chiron Capital Management LLC10,000$38K0.0%N/A0.019%
5/19/2021Squarepoint Ops LLC11,650$44K0.0%N/A0.022%
5/18/2021Citadel Advisors LLC49,378$188K0.0%N/A0.093%
5/17/2021Royal Bank of Canada27,381$105K0.0%-23.0%0.052%
5/17/2021Goldman Sachs Group Inc.10,300$39K0.0%N/A0.019%
5/12/2021Geode Capital Management LLC24,545$92K0.0%+51.4%0.046%
5/12/2021JPMorgan Chase & Co.56,283$214K0.0%N/A0.107%
5/11/2021Toronto Dominion Bank22,465$85K0.0%+190.5%0.043%
5/11/2021 Banque Cantonale Vaudoise11,268$42K0.0%+723.7%0.021%
4/26/2021Brave Asset Management Inc.10,000$38K0.0%N/A0.019%
4/19/2021 International Assets Investment Management LLC277,852$885K0.1%+130.1%0.533%
2/24/2021Virtu Financial LLC19,587$47K0.0%N/A0.047%
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
2/10/2021Renaissance Technologies LLC174,220$415K0.0%+1,284.3%0.418%
1/29/2021Creative Planning180,000$428K0.0%+5.9%0.390%
1/22/2021 International Assets Investment Management LLC120,776$287K0.1%+29.3%0.290%
11/12/2020JPMorgan Chase & Co.16,483$101K0.0%+212.0%0.040%
10/21/2020 International Assets Investment Management LLC93,411$158K0.0%+185.8%0.224%
10/20/2020Wedbush Securities Inc.111,600$189K0.0%-23.9%0.268%
8/7/2020Virtu Financial LLC15,490$29K0.0%N/A0.038%
7/23/2020Creative Planning110,000$207K0.0%+18.3%0.272%
7/22/2020 Financial Consulate Inc.41,474$78K0.0%N/A0.102%
7/20/2020 International Assets Investment Management LLC32,687$61K0.0%+131.2%0.081%
7/16/2020Wedbush Securities Inc.146,605$276K0.0%+227.9%0.362%
5/15/2020Morgan Stanley425,212$587K0.0%+203.1%1.146%
5/15/2020Two Sigma Advisers LP150,700$208K0.0%N/A0.406%
5/5/2020Creative Planning93,000$128K0.0%N/A0.251%
(Data available from 1/1/2016 forward)

ONCY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ONCY shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Oncolytics Biotech. The most heavily invested institutionals were International Assets Investment Management LLC ($364K), Advisor Resource Council ($135K), Bank of Montreal Can ($85K), Brave Asset Management Inc. ($55K), Lynwood Capital Management Inc. ($41K), Ausdal Financial Partners Inc. ($40K), and Toronto Dominion Bank ($34K).Learn more on ONCY's institutional investors.

What percentage of Oncolytics Biotech stock is owned by institutional investors?

6.82% of Oncolytics Biotech stock is owned by institutional investors. Learn more on ONCY's institutional investor holdings.

Which institutional investors have been buying Oncolytics Biotech stock?

Of the 9 institutional investors that purchased Oncolytics Biotech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Advisor Resource Council ($200K), International Assets Investment Management LLC ($87.57K), Toronto Dominion Bank ($35.36K), Bank of Montreal Can ($32.38K), Ausdal Financial Partners Inc. ($30K), Brave Asset Management Inc. ($25K), and Lynwood Capital Management Inc. ($25K).

How much institutional buying is happening at Oncolytics Biotech?

Institutional investors have bought a total of 452,842 shares in the last 24 months. This purchase volume represents approximately $689.13K in transactions.

Which Oncolytics Biotech major shareholders have been selling company stock?

The following institutional investors have sold Oncolytics Biotech stock in the last 24 months: International Assets Investment Management LLC ($12.47K).

How much institutional selling is happening at Oncolytics Biotech?

Institutional investors have sold a total of 12,465 shares in the last 24 months. This volume of shares sold represents approximately $20.32K in transactions.


Related Companies:
This page (NASDAQ:ONCY) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Fed launches fourth dollar overhaul
Stansberry Research
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press